IRadimed Corporation IRMD
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 24.20M | 20.47M | 21.98M | 22.69M | 21.20M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 24.20M | 20.47M | 21.98M | 22.69M | 21.20M |
| Cost of Revenue | 5.75M | 5.31M | 5.17M | 5.66M | 4.71M |
| Gross Profit | 18.46M | 15.16M | 16.81M | 17.03M | 16.49M |
| SG&A Expenses | 9.44M | 8.11M | 8.62M | 9.16M | 8.99M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 16.06M | 14.08M | 14.74M | 15.60M | 14.37M |
| Operating Income | 8.14M | 6.39M | 7.24M | 7.09M | 6.83M |
| Income Before Tax | 8.67M | 6.89M | 7.77M | 7.79M | 7.30M |
| Income Tax Expenses | 2.16M | 1.67M | 1.95M | 1.35M | 1.72M |
| Earnings from Continuing Operations | 6.51M | 5.22M | 5.82M | 6.44M | 5.58M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 6.51M | 5.22M | 5.82M | 6.44M | 5.58M |
| EBIT | 8.14M | 6.39M | 7.24M | 7.09M | 6.83M |
| EBITDA | 8.55M | 6.80M | 7.69M | 7.47M | 7.22M |
| EPS Basic | 0.51 | 0.41 | 0.46 | 0.51 | 0.44 |
| Normalized Basic EPS | 0.42 | 0.34 | 0.38 | 0.37 | 0.36 |
| EPS Diluted | 0.51 | 0.41 | 0.45 | 0.50 | 0.43 |
| Normalized Diluted EPS | 0.42 | 0.33 | 0.38 | 0.37 | 0.35 |
| Average Basic Shares Outstanding | 12.79M | 12.78M | 12.78M | 12.74M | 12.72M |
| Average Diluted Shares Outstanding | 12.88M | 12.87M | 12.87M | 12.88M | 12.86M |
| Dividend Per Share | 0.20 | 0.20 | 0.20 | 0.20 | 0.17 |
| Payout Ratio | 39.32% | 49.00% | 43.93% | 132.79% | 38.79% |